4.7
만성 기관지염은 만성 폐쇄성 폐질환(COPD)의 주요 표현형으로, 기도 중심 염증과 점액 과다 생성이 특징입니다. 이는 유해 입자나 가스, 특히 담배 연기에 장기간 노출되어 지속적인 염증 반응을 유발하면서 발생합니다.
염증은 처음에는 큰 기관지에 영향…
만성 기관지염은 COPD의 주요 표현형으로, 담배 연기와 같은 공기 중 자극물에 장기간 노출되어 발생합니다.
이 자극물질들은 큰 기관지에서 시작해 작은 기도로 확장되는 지속적인 염증을 유발합니다.
호중구, 대식세포, 림프구가 기관지 벽으로 침투하여 상피 손상을 일으킵니다.
염증은 또한 편평 화생을 유발하는데, 이는 섬모 상피를 편평세포로 대체하여 점액 섬모 정리를 방해합니다.
한편, 고블릿 세포와 점막하 분비선은 과형성과 비대를 겪으며, 기도를 막고 감염을 촉진하는 두꺼운 점액을 생성합니다.
지속적인 염증과 점액 막힘은 기도 재형성을 초래하며, 평활근 비대와 섬유화를 포함해 특히 호기 시 기도를 좁히게 됩니다.
기도 폐쇄는 환기와 관류 불일치를 일으켜 저산소혈증으로 이어집니다. 점진적인 공기 포획은 과팽창을 일으켜 횡격막을 평평하게 만들고, 환기 효율을 낮추며, 호흡 작업을 증가시킵니다.
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic bronchitis to develop?
Chronic bronchitis develops from prolonged exposure to airborne irritants, most commonly cigarette smoke. These irritants trigger persistent inflammation that begins in the larger bronchi and extends into smaller airways. Neutrophils, macrophages, and lymphocytes infiltrate the bronchial walls, causing epithelial injury and initiating a cascade of structural and functional changes.
Q2: How does squamous metaplasia affect the airways in chronic bronchitis?
Squamous metaplasia replaces the ciliated epithelium with non-ciliated squamous cells, impairing mucociliary clearance. This loss of ciliated cells reduces the airway's ability to trap and remove mucus and pathogens, increasing infection risk and allowing mucus to accumulate and damage airways progressively.
Q3: Why do goblet cells and submucosal glands enlarge in chronic bronchitis?
Persistent inflammation triggers hyperplasia and hypertrophy of goblet cells and submucosal glands. These enlarged structures produce excessive, thick mucus that clogs airways and promotes bacterial colonization. The increased Reid index reflects glands occupying over half the bronchial wall thickness, contributing to airflow obstruction.
Q4: What is the relationship between airway remodeling and breathing difficulty?
Airway remodeling includes smooth muscle hypertrophy, fibrosis, and inflammatory thickening that narrow airways, especially during expiration. Combined with mucus plugging, this obstruction causes air trapping and hyperinflation, which flattens the diaphragm, reduces tidal volume, and significantly increases the work of breathing.
Q5: How does chronic bronchitis impair gas exchange?
Airway obstruction and mucus plugging create a ventilation-perfusion mismatch where perfusion exceeds ventilation. This mismatch leads to hypoxemia and, in advanced cases, hypercapnia due to poor carbon dioxide clearance. Progressive airway damage reduces the lungs' ability to oxygenate blood and eliminate carbon dioxide effectively.
Q6: What are the main clinical symptoms of chronic bronchitis?
Chronic bronchitis presents with chronic productive cough, dyspnea, and frequent infections. These symptoms result from persistent airway inflammation, excessive mucus production, and impaired clearance mechanisms. Although lung parenchyma is relatively preserved compared to emphysema, progressive airway damage leads to declining lung function and worsening symptoms.
Q7: How does chronic bronchitis differ from emphysema in COPD?
Chronic bronchitis is characterized by airway-centered inflammation and mucus overproduction with relatively preserved lung parenchyma. In contrast, emphysema involves parenchymal destruction. Understanding both phenotypes is essential for recognizing that chronic obstructive pulmonary disease emphysema and chronic bronchitis represent distinct pathological processes within COPD.